Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients

Código QR

Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients

Guardado en:

Detalles Bibliográficos
Autores principales:	Yasmin Adel, Yousra Sadeq
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2020
Materias:	systemic lupus erythematosus interleukin interferon disease activity Medicine R
Acceso en línea:	https://doaj.org/article/c6592f6b41de47ccb3337ab8032c6f5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical significance of interferon lambda-3 (IFNλ3)/interleukin 28B (IL28B) in systemic lupus erythematosus patients
por: Fatma H. Abdelraouf, et al.
Publicado: (2022)

Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic
por: Samar Tharwat, et al.
Publicado: (2021)

Bullous systemic lupus erythematosus: exceptional and challenging presentation
por: Salem Bouomrani, et al.
Publicado: (2020)

Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy
por: Helena Idborg, et al.
Publicado: (2021)

Lupus
Publicado: (1991)

Interleukin-23 serum level in systemic lupus erythematosus patients: Relation to disease activity and different disease parameters
por: Shimaa Rafat, et al.
Publicado: (2022)

Transverse myelitis and chronic urticaria in systemic lupus erythematosus: Case report
por: dos Santos,Vitorino Modesto, et al.
Publicado: (2005)

Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression
por: Rosalie Magro, et al.
Publicado: (2021)

Canine perianal furunculosis and interdigital lesions: Probable systemic lupus erythematosus
por: Ojeda,J, et al.
Publicado: (2010)

Massive and painful ascites as a presenting manifestation of systemic lupus erythematosus flare: a case report and literature review
por: Zhou,Lei, et al.
Publicado: (2014)

Follow-up and management of serologically active clinically quiescent cases in pediatric systemic lupus erythematosus
por: Gabrielle Capone, et al.
Publicado: (2021)

Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
por: Liu S, et al.
Publicado: (2021)

Lupus eritematoso asociado a eritema multiforme: Síndrome de Rowell. Reporte del primer caso en Chile
por: Heredia,Loreto, et al.
Publicado: (2020)

Systemic lupus erythematosus and critical illness polyneuropathy
por: Maria Katkowska, et al.
Publicado: (2021)

Netosis in patients with systemic lupus erythematosus
por: V. V. Zhelezko, et al.
Publicado: (2020)

Audiologic evaluation in systemic lupus erythematosus patients and impact of hydroxychloroquine therapy
por: Samar Tharwat, et al.
Publicado: (2022)

RISK FACTORS AND PREDICTION OF DEVELOPMENT OF DYSCIRCULATORY ENCEPHALOPATHY IN WOMEN WITH SYSTEM LUPUS ERYTHEMATOSUS
por: D. L. Faizulina, et al.
Publicado: (2012)

Celiac disease in patients with systemic lupus erythematosus
por: Zahra Soltani, et al.
Publicado: (2021)

White rosette in discoid lupus erythematosus: a new dermoscopic observation
por: Balachandra S. Ankad, et al.
Publicado: (2017)

Dermoscopic Appearance of an Annular Subacute Cutaneous Lupus Erythematosus
por: Biswanath Behera, et al.
Publicado: (2021)

Psoriasis and systemic lupus erythematosus in children – literature review based on case report
por: Izabela Dybowska-Gołota, et al.
Publicado: (2020)

Management of systemic lupus erythematosus during pregnancy: challenges and solutions
por: Knight CL, et al.
Publicado: (2017)

The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics
por: Xirui Guo, et al.
Publicado: (2021)

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
por: Chessa E, et al.
Publicado: (2017)

Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions
por: Alessio Buonavoglia, et al.
Publicado: (2021)

Acute mesenteric lymphadenitis revealing systemic lupus erythematosus
por: Salem Bouomrani, et al.
Publicado: (2020)

Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-α signature
por: Yuan-yuan Qi, et al.
Publicado: (2021)

Uso de metotrexato en pacientes con lupus eritematoso sistémico
por: Sánchez H,Yunchoy, et al.
Publicado: (2004)

Osteomyelitis and septic arthritis in neonatal lupus erythematosus patients
por: Virany Diana, et al.
Publicado: (2022)

Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
por: Suárez H,Felipe, et al.
Publicado: (2016)

Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus
por: Marco Manfredini, et al.
Publicado: (2021)

Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
por: Eleni Klimi, et al.
Publicado: (2021)

A Case of Systemic Lupus Erythematosus without Antiphospholipid Syndrome Causing Superior Vena Cava Syndrome
por: Vivek Choudhary, et al.
Publicado: (2021)

Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
por: Carrión A,Flavio, et al.
Publicado: (2003)

Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients
por: Atik N, et al.
Publicado: (2020)

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios K, et al.
Publicado: (2016)

Tetracyclines Diminish In Vitro IFN-γ and IL-17-Producing Adaptive and Innate Immune Cells in Multiple Sclerosis
por: Despoina T. Florou, et al.
Publicado: (2021)

Evaluation of Central and Peripheral Corneal Thicknesses in Patients with Systemic Lupus Erythematosus
por: Eissa IM, et al.
Publicado: (2020)

Emerging B-Cell Therapies in Systemic Lupus Erythematosus
por: Bag-Ozbek A, et al.
Publicado: (2021)

Autoantibody Profile of Egyptian Juvenile Systemic Lupus Erythematosus Patients and Its Association with Clinical Characteristics and Disease Activity
por: Abd El Monem Teama M, et al.
Publicado: (2021)